A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

University of California, Berkeley biochemist Jennifer Doudna won the 2020 Nobel Prize in Chemistry alongside Emmanuelle Charpentier for their pioneering work on CRISPR-Cas9. This revolutionary ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...

Founded by Nobel prize winner Emmanuelle Charpentier, CRISPR Therapeutics has been at the forefront of gene editing technology and has refined its technology to the point where it can be used to a ...

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

A revolutionary gene therapy treatment costing a staggering £1.65 million has been approved for NHS use, offering patients ...

The National Institute for Health and Care Excellence (NICE) has approved Vertex Pharmaceuticals’ Casgevy (exagamglogene ...

Molecular editing is so promising that it has been the basis of two Nobel Prizes in Chemistry ... Similarly, in 2020, the ...

The UK has approximately 17,500 individuals living with sickle cell disease, a condition particularly prevalent amongst those ...